Neil Johnson

Neil has many years experience in the pharmaceutical industry as a medicinal chemist working in both large pharma and biotech. During his time at GSK he successfully led projects from early discovery to development achieving 3 IND's and contributing to multiple other clinical assets. The majority of his research has been in oncology working on targets ranging from kinase signalling pathways to epigenetics.